If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,070.00    -130.00 (-1.81%)
Bid:
7,080.00
Ask:
7,090.00
Spread: 10.00 (0.141%)
Market Cap: £9.48b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Q3 Trading Update

17 Jul 2025 07:00

RNS Number : 3603R
Diploma PLC
17 July 2025
 

10-11 CHARTERHOUSE SQUARE, LONDON EC1M 6EE

TELEPHONE: +44 (0)20 7549 5700

 

17 July 2025

 

STRONG Q3. FURTHER FY UPGRADE.

TWO ACQUISITIONS.

 

 

Diploma PLC issues a trading update for the nine months ended 30 June 2025.

 

· Strong Q3 performance. Full year upgrade to organic growth of 10% (from 8%).

Organic growth YTD of 10%: continuation of positive trends from H1.

Reported growth YTD of 12%: +4% from acquisitions, partly offset by FX.

Strong operating margin: in line with expectations (FY guidance c.22%).

 

· Invested c.£39m in two quality acquisitions:

Haagensen A/S (Seals), adding to M-Seals' capability in Denmark.

Alpha Laboratories (Life Sciences), marks our entry into the UK In Vitro Diagnostics market.

 

 

 

---------------------------------------------------------------------------------------------------

Johnny Thomson, Chief Executive Officer, and Chris Davies, Chief Financial Officer, will host a conference call for analysts and investors this morning at 8:00am (UK time).

 

Conference call dial in details:

• Dial in: +44 (0) 33 0551 0200

• Password: Diploma Q3

 

The next scheduled update is our full year results on 18 November 2025.

 

 

 

For further information please contact:

Diploma PLC -

+44 (0)20 7549 5700

Johnny Thomson, Chief Executive Officer

 

Chris Davies, Chief Financial Officer

Holly Gillis, Head of Investor Relations

Teneo -

+44 (0)20 7353 4200

Martin Robinson

Camilla Cunningham

 

 

 

 

 

 

 

NOTE TO EDITORS:

 

Diploma's businesses deliver practical and innovative solutions that keep key industries moving. They have the technical expertise, specialist knowledge, and long-term relationships required to deliver value-add products and services that make our customers' lives easier and their outcomes better. These value-add solutions drive customer loyalty, market share growth and strong margins.

 

Our decentralised model means our specialist businesses are agile and empowered to deliver the right solutions for their customers, in their own way. As part of Diploma, our businesses can also leverage the additional resources, opportunities and expertise of a large, international and diversified Group to benefit their customers, colleagues, suppliers and communities.

 

We employ c.3,300 colleagues across our three Sectors of Controls, Seals and Life Sciences. Our principal operating businesses are located in North America, the UK, Europe, and Australia.

 

Diploma aims to deliver sustainable quality compounding, and over the last fifteen years, the Group has grown adjusted earnings per share (EPS) at an average of c.16% p.a. through a combination of organic growth and acquisitions.

Diploma is a member of the FTSE 100.

 

Further information on Diploma PLC can be found at www.diplomaplc.com

 

The person responsible for releasing this Announcement is Anna Lawrence, Group Company Secretary.

LEI: 2138008OGI7VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUBPMUPAGAQ
Date   Source Headline
11th Dec 201511:38 amRNSDirector/PDMR Shareholding
9th Dec 20154:00 pmRNSAnnual Financial Report and Notice of AGM
30th Nov 201510:00 amRNSHolding(s) in Company
17th Nov 201510:00 amRNSDirectorate Change
16th Nov 20157:00 amRNSFinal Results
27th Oct 201512:10 pmRNSHolding(s) in Company
30th Sep 20159:31 amRNSDirector/PDMR Shareholding
25th Sep 201510:01 amRNSDirector/PDMR Shareholding
24th Sep 20159:12 amRNSHolding(s) in Company
24th Sep 20159:00 amRNSHolding(s) in Company
23rd Sep 20154:50 pmRNSDirector/PDMR Shareholding
14th Sep 201511:43 amRNSHolding(s) in Company
8th Sep 20157:00 amRNSDirectorate Changes
3rd Sep 20153:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20157:02 amRNSDirectorate Change
2nd Sep 20157:00 amRNSTrading Update
24th Aug 20159:47 amRNSHolding(s) in Company
24th Aug 20157:00 amRNSHolding(s) in Company
10th Jul 20157:00 amRNSNotice of Trading Update
5th Jun 201511:00 amRNSDirector Declaration
14th May 20154:00 pmRNSDirector/PDMR Shareholding
11th May 20157:00 amRNSInterim Management Statement
31st Mar 201510:04 amRNSDirector/PDMR Shareholding
30th Mar 20157:00 amRNSTrading Statement
13th Mar 20157:00 amRNSAcquisition
27th Feb 20157:00 amRNSDirectorate Change
10th Feb 20157:00 amRNSAppointment of Non-Executive Director
5th Feb 20154:00 pmRNSDirector/PDMR Shareholding
27th Jan 20155:28 pmRNSHolding(s) in Company
21st Jan 20155:00 pmRNSResult of AGM
21st Jan 20154:42 pmRNSDirectorate Change
21st Jan 20157:00 amRNSTrading Statement
5th Dec 20144:00 pmRNSAnnual Financial Report and Notice of AGM
27th Nov 20141:28 pmRNSHolding(s) in Company
25th Nov 20144:00 pmRNSDirector/PDMR Shareholding
17th Nov 20147:00 amRNSPreliminary Announcement of Results
12th Nov 20147:00 amRNSDirectorate Change
7th Oct 20147:00 amRNSAcquisition
29th Sep 20147:00 amRNSTrading Statement
17th Sep 20143:24 pmRNSHolding(s) in Company
9th Sep 201410:04 amRNSDirector/PDMR Shareholding
22nd Aug 20149:41 amRNSHolding(s) in Company
30th Jul 20147:00 amRNSInterim Management Statement
3rd Jul 201410:04 amRNSDirector/PDMR Shareholding
3rd Jul 20149:26 amRNSHolding(s) in Company
19th Jun 201412:00 pmRNSHolding(s) in Company
13th Jun 20149:46 amRNSHolding(s) in Company
22nd May 20149:44 amRNSHolding(s) in Company
12th May 20147:00 amRNSHalf Yearly Report
28th Apr 201410:00 amRNSNotice of 2014 Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.